Patient Outcome of Cardiac Surgery During the COVID-19 Pandemic

Condition(s) studied

Investigational drug(s) / intervention(s)

No intervention: No description

Study summary

This study will describe the recovery process of patients undergoing cardiac surgery during the covid-19 pandemic. This will focus on hemodynamic failure and organ dysfunction after surgery.

Capturing real-world data and sharing international experience will inform the management of this complex group of patients who undergo surgery throughout the COVID-19 pandemic, improving their clinical care.

This investigator-led, non-commercial, non-interventional does not collect any patient identifiable information.

Eligibility

Primary outcome measure(s)

• Highest VIS (Vasoactive-Inotropic Score) in the first 12 hours postoperatively. — 12 hours post-operatively
  The VIS score correlates with mortality after cardiac surgery and reflects the degree of patient hemodynamic failure. This score is calculated as follows: ISR = Dobutamine dose in g/kg/min + 100 times the Adrenaline dose in g/kg/min + 100 times the Noradrenaline dose in g/kg/min + 10,000 times the Vasopressin dose in U/kg/min.

Trial sites (1)

More Nantes University Hospital trials in France